Market Place
Sourcing Support
All News #Library
Rare Diseases
Relief Pharma Reports Positive Results In RLF-OD032 Study
29 Oct 2025 //
ACCESSWIRE
Relief Gets FDA Rare Pediatric Tag For RLF-TD011
22 May 2025 //
ACCESSWIRE
Relief Therapeutics Reports 2024 Financial Results & Update
10 Apr 2025 //
ACCESSWIRE
Relief Announces Results of RLF-TD011 in Epidermolysis Bullosa
11 Nov 2024 //
ACCESSWIRE
Relief Therapeutics Announces Promising Results. RLF-TD011 trial.
08 Oct 2024 //
ACCESSWIRE
Relief Reports Positive Results For Phenylketonuria Study
04 Oct 2024 //
ACCESSWIRE
Relief Therapeutics & World Orphan Drug Alliance Announce an Exclusive Agreement
23 Jun 2023 //
ACCESSWIRE
Relief Announces U.S. Availability of New PKU GOLIKE Bars
28 Feb 2023 //
ACCESSWIRE
Acer, Relief win FDA approval for rare disease after clearing inspection
28 Dec 2022 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.